Drug intelligence / Profile preview

miconazole

Development stage
Approved
Lead developer
Insight Pharmaceuticals
Modality
Small Molecules
Administration
Topical, Intravaginal, Buccal
01

Overview

Miconazole is a synthetic imidazole antifungal agent used to treat a variety of fungal infections, including those affecting the skin (such as athlete's foot, jock itch, and ringworm), vagina (vulvovaginal candidiasis), and mouth (oropharyngeal candidiasis)[1][2][3][4][5]. It is available in multiple topical and intravaginal formulations. Miconazole acts primarily by inhibiting the fungal enzyme 14α-lanosterol demethylase, a key component of the CYP450 complex. This inhibition disrupts ergosterol synthesis, leading to altered cell membrane composition and increased permeability, which results in leakage of cellular contents and ultimately inhibits fungal growth[3][5][6]. Miconazole also exhibits some activity against Gram-positive bacteria[3]. The drug was first synthesized in 1969 and received FDA approval in 1974. It is minimally absorbed systemically when applied topically but can be absorbed through mucosal surfaces[5].

Brand names
MonistatAloe Vesta Clear AntifungalAzolenBaza AntifungalCritic-Aid Clear AFCruex Prescription Strength
Other names
miconazole nitrate
02

Targets

GR (Glucocorticoid receptor)CYP51A1 (Sterol 14α-demethylase)

Beyond the preview

Go deeper on miconazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miconazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call